Everest Medicines Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2018 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2018 - 2019
Revenue	706.68	125.93	12.79	0.05	-	Upgrade
Revenue Growth (YoY)	461.16%	884.46%	23588.89%	-	-	Upgrade
Cost of Revenue	177.79	34.41	4.65	0.02	-	Upgrade
Gross Profit	528.89	91.52	8.15	0.03	-	Upgrade
Selling, General & Admin	758.15	396.57	603.23	440.83	311.08	Upgrade
Research & Development	528.04	540.05	809.74	613.43	377.41	Upgrade
Other Operating Expenses	22.92	6.16	-0.12	-4.96	-0.98	Upgrade
Operating Expenses	1,309	942.78	1,413	1,049	687.51	Upgrade
Operating Income	-780.21	-851.27	-1,405	-1,049	-687.51	Upgrade
Interest Expense	-22.19	-23.06	-5.59	-4.81	-33.87	Upgrade
Interest & Investment Income	95.21	107.67	38.48	28.88	2.04	Upgrade
Currency Exchange Gain (Loss)	19.51	-28.07	-155.18	22.94	-0.85	Upgrade
Other Non Operating Income (Expenses)	2.65	2.82	-1.61	-6.46	-4,938	Upgrade
EBT Excluding Unusual Items	-685.03	-791.91	-1,529	-1,009	-5,658	Upgrade
Gain (Loss) on Sale of Investments	-0.01	0.85	-21.75	-	-	Upgrade
Gain (Loss) on Sale of Assets	-	-1.43	1,320	-	-	Upgrade
Asset Writedown	-356.34	-51.97	-16.49	-	-	Upgrade
Pretax Income	-1,041	-844.46	-247.28	-1,009	-5,658	Upgrade
Income Tax Expense	-	-	0.01	-	-	Upgrade
Net Income	-1,041	-844.46	-247.28	-1,009	-5,658	Upgrade
Net Income to Common	-1,041	-844.46	-247.28	-1,009	-5,658	Upgrade
Shares Outstanding (Basic)	321	313	298	293	85	Upgrade
Shares Outstanding (Diluted)	321	313	298	293	85	Upgrade
Shares Change (YoY)	2.51%	5.18%	1.49%	243.61%	1532.82%	Upgrade
EPS (Basic)	-3.24	-2.70	-0.83	-3.44	-66.29	Upgrade
EPS (Diluted)	-3.24	-2.70	-0.83	-3.44	-66.29	Upgrade
Free Cash Flow	-744.92	-886.53	-1,512	-839.89	-480.5	Upgrade
Free Cash Flow Per Share	-2.32	-2.83	-5.08	-2.86	-5.63	Upgrade
Gross Margin	74.84%	72.67%	63.69%	57.41%	-	Upgrade
Operating Margin	-110.41%	-675.97%	-10981.12%	-1943096.30%	-	Upgrade
Profit Margin	-147.36%	-670.57%	-1933.11%	-1867998.15%	-	Upgrade
Free Cash Flow Margin	-105.41%	-703.97%	-11817.36%	-1555344.44%	-	Upgrade
EBITDA	-670.04	-795.72	-1,391	-1,043	-683.03	Upgrade
EBITDA Margin	-94.82%	-	-	-	-	Upgrade
D&A For EBITDA	110.17	55.55	13.81	6.21	4.48	Upgrade
EBIT	-780.21	-851.27	-1,405	-1,049	-687.51	Upgrade
EBIT Margin	-110.41%	-	-	-	-	Upgrade

Updated Aug 28, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.